MELTON B AFFRIME
Pharmacy in Warren, NJ
License number
New Jersey 28RI01718700
Issued Date
Jan 2, 1983
Category
Pharmacy
Type
Pharmacist
Address
Address
Warren, NJ
Personal information
See more information about MELTON B AFFRIME at radaris.comName
Address
Phone
11 Whispering Way, Warren, NJ 07059
2 Horseshoe Dr, Flemington, NJ 08822
Professional information
Use Of Desloratadine For Treating Allergic And Inflammatory Conditions
US Patent:
2004013, Jul 15, 2004
Filed:
Dec 24, 2003
Appl. No.:
10/743862
Inventors:
Melton Affrime - Warren NJ, US
Christopher Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
Christopher Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
International Classification:
A61K031/473
US Classification:
514/290000
Abstract:
The use of desloratadine for the preparation of a medicament for treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages in a human while avoiding the food effect associated with non-sedating antihistamines, e.g., loratadine or fexofenadine is disclosed.
Treating Allergic And Inflammatory Conditions
US Patent:
2003000, Jan 2, 2003
Filed:
May 21, 2002
Appl. No.:
10/130763
Inventors:
Melton Affrime - Warren NJ, US
Christhoper Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
Christhoper Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
International Classification:
A61K031/473
US Classification:
514/290000
Abstract:
The use of desloratadine for the preparation of a medicament for treating and/or preventing an allergic and inflammatory condition of the skin or upper and lower airway passages in a pediatric patient and a pediatric pharmaceutical composition effective for such treating and/or preventing which comprises an effective amount of desloratadine and a pharmaceutically acceptable carrier are disclosed.
Treating Allergic And Inflammatory Conditions
US Patent:
7902208, Mar 8, 2011
Filed:
May 30, 2008
Appl. No.:
12/155250
Inventors:
Melton B. Affrime - Warren NJ, US
Christopher R. Banfield - High Bridge NJ, US
Samir K. Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
Christopher R. Banfield - High Bridge NJ, US
Samir K. Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/44
US Classification:
514290, 514960
Abstract:
A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e. g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e. g. 2×2. 5 mg or 5 mg/day for a time sufficient to produce a geometric mean steady state maximum plasma concentration of desloratadine in the range of about 2. 90 ng/mL to about 4. 54 ng/mL, or a arithmetic mean steady state maximum plasma concentration of desloratadine in the range of about 3. 2 ng/mL to about 5. 0 ng/mL is disclosed.
Treating Allergic And Inflammatory Conditions
US Patent:
7405223, Jul 29, 2008
Filed:
Jan 16, 2001
Appl. No.:
09/760588
Inventors:
Melton B. Affrime - Warren NJ, US
Christopher R. Banfield - High Bridge NJ, US
Samir K. Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
Christopher R. Banfield - High Bridge NJ, US
Samir K. Gupta - East Brunswick NJ, US
Desmond Padhi - Thousand Oaks CA, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/44
US Classification:
514290, 514960
Abstract:
A method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages, e. g. seasonal allergic rhinitis, perennial allergic rhinitis, or chronic idopathic urticaria, in a human more 12 years old, by administering an amount of desloratadine, e. g. 2×2. 5 mg or 5 mg/day for a time sufficient to produce a geometric mean steady state maximum plasma concentration of desloratadine in the range of about 2. 90 ng/mL to about 4. 54 ng/mL, or a arithmetic mean steady state maximum plasma concentration of desloratadine in the range of about 3. 2 ng/mL to about 5. 0 ng/mL is disclosed.
Treating Allergic And Inflammatory Conditions
US Patent:
2006015, Jul 13, 2006
Filed:
Jan 12, 2005
Appl. No.:
11/033919
Inventors:
Melton Affrime - Warren NJ, US
Christopher Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
Christopher Banfield - High Bridge NJ, US
Samir Gupta - East Brunswick NJ, US
International Classification:
A61K 31/473
US Classification:
514290000
Abstract:
The use of desloratadine for the preparation of a medicament for treating and/or preventing an allergic and inflammatory condition of the skin or upper and lower airway passages in a pediatric patient and a pediatric pharmaceutical composition effective for such treating and/or preventing which comprises an effective amount of desloratadine and a pharmaceutically acceptable carrier are disclosed.